Banned Alzheimer's drug 'could improve quality of life'
02 December 2008
 A banned Alzheimer's drug could significantly improve the quality of life of sufferers, according to new research. The medication, galantamine, can be prescribed to slow the progression of the debilitating neurological disease in people with mild symptoms.Professor Alistair Burns at the University of Manchester has reignited the debate surrounding the medication, which contains Acetylcholinesterase inhibitors, according to OnMedica.Earlier this year, the professor made similar claims about the treatment in Lancet Neurology and put pressure on the National Institute for Health and Clinical Excellence to reinstate the drug.He said: "The data show that there are untreated patients with severe AD in nursing homes who could benefit from starting treatment with galantamine."According to the Alzheimer's Society, some doctors have place a separation between mild cognitive impairment (MCI) – such as memory loss – and Alzheimer's.The charity states that there is a low risk of MCI developing into the condition. © 2008 Adfero Ltd. All rights reserved. Any views and opinions expressed in news articles are not those of Craegmoor Limited and its associated companies. News supplied by Adfero DirectNews.
Bookmark with:
What are these?
 Delicious
 Digg
 reddit
 Facebook
 StumbleUpon
Related stories
23/12/2008 GPs to get dementia training
All GPs in England are to receive training on how to spot the early symptoms of dementia in plans by the government to improve the quality of life for patients.
19/12/2008 MRI scans 'capable of early Alzheimer's diagnosis'
MRI scans can be used to detect the onset of Alzheimer's before physical symptoms become apparent, according to new research.
17/12/2008 Sarcasm may hold key to dementia diagnosis
Being unable to spot sarcasm may signal the early onset of frontotemporal dementia (FTD) in the young, it has been claimed.
15/12/2008 University awarded £100,000 Alzheimer's funding
The Alzheimer's Research Trust (ART) has award the University of Ulster £100,000 to fund a dementia study being carried out by the institution.
11/12/2008 Government mental health adviser visits Staffordshire trust
A leading government mental health expert has visited South Staffordshire Primary Care Trust (PCT) to look at how the organisation is dealing with Alzheimer's and other mental illnesses, it has been reported.
|